PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
16-Nov-2020 SynDevRx Announces Positive Data from Phase 1 Safety Trial of SDX-7320 in Late Stage Cancer Patients SynDevRx
16-Nov-2020 AMZELL to initiate FDA-approved Phase 3 trial of innovative injectable treatment for infantile epileptic disease AMZELL B.V
16-Nov-2020 Q BioMed’s Uttroside-B Receives U.S. Patent in Treatment of Liver Cancer Q BioMed Inc
16-Nov-2020 Envision Pharma Group acquires Two Labs to advance its position as a global strategic partner to pharma and create a unique and unrivaled launch excellence offering Envision Pharma Group
16-Nov-2020 Myricx Pharma Launches with £4.5M Financing to Progress its Novel NMT inhibitors in Cancer Myricx Pharma
16-Nov-2020 Bone Therapeutics announces completion of the acquisition of its cell therapy manufacturing subsidiary SCTS by Catalent Bone Therapeutics
16-Nov-2020 Calypso Biotech Announces Successful Dosing of First Phase 1 Cohort with Anti-Interleukin-15 (IL-15) Monoclonal Antibody CALY-002 for the Treatment of Autoimmune Diseases Calypso Biotech
16-Nov-2020 Farxiga showed cardiovascular and renal benefit in patients with chronic kidney disease irrespective of cardiovascular disease status AstraZeneca 
16-Nov-2020 Full results from AFFIRM-AHF study show Ferinject® significantly reduces hospitalizations after acute heart failure in patients with iron deficiency Vifor Pharma
15-Nov-2020 Johnson & Johnson Initiates Second Global Phase 3 Clinical Trial of its Janssen COVID-19 Vaccine Candidate Johnson & Johnson
13-Nov-2020 AlzeCure receives approval to start clinical Phase I trial with ACD856 in Alzheimer's disease AlzeCure
12-Nov-2020 Pioneering research detects Hormone-Upregulated lncRNA within the lymphocyte-specific protein tyrosine kinase (HULLK) discovered in Prostate Cancer APIS Assay Technologies Ltd
12-Nov-2020 Isohelix and Precision Genetics Partner to Expand COVID-19 Testing Using Saliva Collection Technology Isohelix
12-Nov-2020 Cardior Pharmaceuticals Announces Positive Phase Ib Results of its Lead Compound CDR132L in Heart Failure Cardior Pharmaceuticals
11-Nov-2020 Tiziana Life Sciences announces collaboration with Parexel Biotech to conduct phase 1b/2 clinical trial in patients with Crohn’s Disease Tiziana Life Sciences
10-Nov-2020 PharmiWeb.Jobs Welcomes Marketplace Technical PharmiWeb.Jobs
10-Nov-2020 Celltrion presents positive Phase I trial results for potential treatment candidate CT-P59 in patients with mild symptoms of COVID-19 Celltrion
10-Nov-2020 Semaglutide 2.4 mg injection demonstrated significant weight loss versus placebo when added to intensive behavioural therapy Novo Nordisk
10-Nov-2020 COVID-19 VACCINE COMMENT: Pfizer’s COVID-19 vaccine results show initial promise – diversity focus must also be applauded Innovative Trials
10-Nov-2020 Tezepelumab NAVIGATOR Phase III trial met primary endpoint of a statistically significant and clinically meaningful reduction in exacerbations in a broad population of patients with severe asthma AstraZeneca